Page 1

ORGANON ™ Media Contacts : Karissa Peer ( 614 ) 314-8094 Kate Vossen Investor Contacts : Jennifer Halchak ( 201 ) 275-2711 Edward Barger ( 732 ) 675-8448 ( 267 ) 614-4669 Organon reports results for the third quarter ended September 30 , 2021 • Third quarter 2021 revenue of $ 1,600 million Exhibit 99.1 • • • • Net income from continuing operations of $ 323 million , or $ 1.27 per diluted share ; Adjusted net income from continuing operations of $ 424 million , or $ 1.67 per diluted share Adjusted EBITDA of $ 636 million Board of Directors declares quarterly dividend of $ 0.28 per share Financial guidance affirmed ; ranges for revenue and Adjusted EBITDA margin , narrowed Executing on business development ; announces acquisition of Forendo Pharma Jersey City , N.J. , November 11 , 2021 - Organon ( NYSE : OGN ) ( the " company " ) , today announced its results for the third quarter and year to date ended September 30 , 2021 . Organon also announced that its Board of Directors declared a quarterly dividend of $ 0.28 for each issued and outstanding share of the company's common stock . The dividend is payable on December 16 , 2021 to stockholders of record at the close of business on November 22 , 2021 . " Just months after becoming a standalone company , we are delivering on what we set out to do . Our year to date results are very much in line with expectations , and with good visibility into the remainder of the year , we are affirming our financial guidance , " said Kevin Ali , Organon's CEO . " Importantly , we have also been disciplined in actioning business development opportunities that have been in the works well prior to spin . Including today's announcement regarding the proposed acquisition of Forendo Pharma , we have executed three transactions in the last six months , demonstrating our commitment to advance innovation in large , underserved markets , which women's health has lacked for decades . " Third quarter 2021 revenue in $ millions Q3 2021 Q3 2020 VPY VPY ex - FX Women's Health 381 424 Biosimilars 140 99 ( 10 ) % 41 % ( 11 ) % 39 % Established Brands 1,027 1,088 ( 6 ) % ( 8 ) % Other ( 1 ) Revenue 52 1,600 2 NM NM 1,613 ( 1 ) % ( 3 ) % ( 1 ) Other represents manufacturing sales to the company's former parent company and other third parties and pre - spin allocated revenue hedge activities